Question 1

Am I eligible for this trial based on my treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this combination of drugs compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of gemcitabine and capecitabine?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of tests will be done to check my progress during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal Cancer clinical trial (NCT01472770). Contact the study team or your healthcare provider for specific answers.

What this study is about